FdaApplication
ANDA 203407
Identifiers
- fda_app_no: ANDA203407
Properties
| Property | Value |
|---|---|
| applicant_name | SAGENT PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2018-08-09 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| METHOTREXATE SODIUM PRESERVATIVE FREE | METHOTREXATE SODIUM | EQ 250MG BASE/10ML (EQ 25MG BASE/ML) | INJECTABLE;INJECTION |
| METHOTREXATE SODIUM PRESERVATIVE FREE | METHOTREXATE SODIUM | EQ 50MG BASE/2ML (EQ 25MG BASE/ML) | INJECTABLE;INJECTION |
| METHOTREXATE SODIUM PRESERVATIVE FREE | METHOTREXATE SODIUM | EQ 1GM BASE/40ML (EQ 25MG BASE/ML) | INJECTABLE;INJECTION |
3 products